Functional Neuromodulation & ADvance II Trial - Deep Brain Stimulation episode artwork

EPISODE · Feb 18, 2021 · 48 MIN

Functional Neuromodulation & ADvance II Trial - Deep Brain Stimulation

from Alzheimer's Speaks · host Lori La Bey

Our host, Lori La Bey talks with Todd Langevin, the CEO of Functional Neuromodulation, about their clinical trial using deep brain stimulation referred to as DBS.  We will find out who the ideal canidates are for their trial, where it's available and how it works.  We will also talk about safety issues since Covid hit and how they are proceeding with their ADvance II trial Contact at FxNeuromod: Email:[email protected] Phone:1-866-296-4040 Press Option #1 Websites: http://www.advancestudy4ad.com/            www.mildalzheimersstudy.com     Contact Lori La Bey with questions or branding needs through www.AlzheimersSpeaks.com Alzheimer's Speaks Radio - Shifting dementia care from crisis to comfort around the world one episode at a time by raising all voices and delivering sounds news, not just sound bites since 2011.Support this Show: https://alzheimersspeaks.com/donate-now/See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Feb 18, 2021

Embed this episode

NOW PLAYING

Functional Neuromodulation & ADvance II Trial - Deep Brain Stimulation

0:00 48:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Alzheimer's Speaks?

This episode is 48 minutes long.

When was this Alzheimer's Speaks episode published?

This episode was published on February 18, 2021.

Can I download this Alzheimer's Speaks episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!